THE SEROEPIDEMIOLOGY OF VARICELLA ZOSTER VIRUS (VZV) IN DIFFERENT AGE GROUPS IN TEHRAN, IRAN

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SHARIFI Z.; EMADI GHANJIN S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Allergy, Asthma and Immunology Year:2005 | Volume:4 | Issue:2 Page(s): 95-98

Download Full-Text

View:

553

Download:

251

Cites:

Information Journal Paper

Title

THE SEROEPIDEMIOLOGY OF VARICELLA ZOSTER VIRUS (VZV) IN DIFFERENT AGE GROUPS IN TEHRAN, IRAN

Author(s)

SHARIFI Z. | EMADI GHANJIN S. | Issue Writer Certificate

Keywords

PREVALENCE

VACCINATION

VARICELLA ZOSTER VIRUS

Abstract

Varicella zoster virus (VZV), the causative agent of chicken pox and shingles, can cause severe systemic infections of the CNS and the respiratory tract in immunocompetent individuals as well as in immunocompromized patients. The aim of this cross-sectional study was to assess the PREVALENCE of antibody VARICELLA ZOSTER VIRUS in different age groups.The enzyme linked immunosorbent assay (ELISA) method was used to assess the presence of anti-VZV antibody.A total of 635 serum samples were collected. Age specific PREVALENCE of IgG antibody to VZV showed a progressive increase with age in both males and females. The overall seroPREVALENCE rate was 83.6%. PREVALENCE of antibodies was 59.7% in the age group of less than 10 years, 60.4 % in 10-14 years, 87.5 % in 15-19 years, 88 % in 20-24 years, 89.4 % in 25-29 years and 87.9 % in 30-39 years.The data show that children should be considered as a target group for prevention programs against VZV infection.

Cites

No record.

References

No record.

Cite

APA: Copy

SHARIFI, Z., & EMADI GHANJIN, S.. (2005). THE SEROEPIDEMIOLOGY OF VARICELLA ZOSTER VIRUS (VZV) IN DIFFERENT AGE GROUPS IN TEHRAN, IRAN. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), 4(2), 95-98. SID. https://sid.ir/paper/291092/en

Vancouver: Copy

SHARIFI Z., EMADI GHANJIN S.. THE SEROEPIDEMIOLOGY OF VARICELLA ZOSTER VIRUS (VZV) IN DIFFERENT AGE GROUPS IN TEHRAN, IRAN. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI)[Internet]. 2005;4(2):95-98. Available from: https://sid.ir/paper/291092/en

IEEE: Copy

Z. SHARIFI, and S. EMADI GHANJIN, “THE SEROEPIDEMIOLOGY OF VARICELLA ZOSTER VIRUS (VZV) IN DIFFERENT AGE GROUPS IN TEHRAN, IRAN,” IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), vol. 4, no. 2, pp. 95–98, 2005, [Online]. Available: https://sid.ir/paper/291092/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops